Eric M. Dube - Jun 1, 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Jun 1, 2021
Transactions value $
-$139,797
Form type
4
Date filed
6/3/2021, 04:07 PM
Next filing
Aug 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$71.2K -4.78K -3.05% $14.89 152K Jun 1, 2021 Direct F1
transaction TVTX Common Stock Sale -$68.6K -4.78K -3.14% $14.35 147K Jun 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan adopted on June 15, 2020 and meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.